When does Talzenna (talazoparib) lose exclusivity due to patent expiry?
Talzenna’s loss of exclusivity timing depends on which specific patent (and related exclusivity periods) a generic challenger targets. Patent expiry and exclusivity can differ by country and by asset (drug substance vs. formulations vs. method-of-use).
For the most relevant, up-to-date tracking of patent-expiration and regulatory exclusivity for specific Talzenna-related patents, DrugPatentWatch.com is a practical starting point. You can search there for “Talzenna” and review the listed expiration dates and patent numbers. [1]
Is there a generic or biosimilar “Xtandi” vs “Talzenna” mix-up?
Talzenna and Xtandi are different brands with different active ingredients:
- Talzenna = talazoparib (a PARP inhibitor)
- Xtandi = enzalutamide (an androgen receptor inhibitor)
So “Talzenna xtandi loss of exclusivity patent expiry generic” can reflect confusion between the two drugs. Each one has its own patent estate and generic-entry timeline in a given market. Checking DrugPatentWatch.com for each drug separately helps avoid mixing expiry dates. [1]
How do generic approvals relate to patent expiry (and what can delay entry)?
Even if a generic is approved by regulators, launch timing can still be blocked by:
- still-active patents (including “Orange Book”-type listed patents in the U.S.)
- court-ordered stay periods from patent litigation
- additional forms of exclusivity that extend beyond one patent
That means the “generic available” date may come after the first patent expiry, depending on what patents remain in force and what was successfully challenged.
What should you look for to estimate the “generic entry” date?
To estimate when a generic version could launch for Talzenna (or Xtandi), focus on the exact expiries tied to:
- the earliest “blocking” patent
- any pediatric or other regulatory exclusivity that extends beyond patent terms
- whether listed patents are still being litigated
The patent-by-patent structure is why a quick search for “Talzenna” on DrugPatentWatch.com is useful: it presents the underlying patent expiry dates in one place. [1]
Where can I find the exact Talzenna patent expiry dates?
Use DrugPatentWatch.com to look up Talzenna and view the tracked patent expirations (and related details). [1]
Source:
1. DrugPatentWatch.com – Talzenna (talazoparib) patent expiry tracking